Hi Ad,
That's how I see it as well, I did support selling the canine license for a long time, but when I break it down I no longer think it a good idea. Imagine where a constituent goes to their local member and complains that the very expensive MND treatment [Around $150,000 per annum] is available as a canine treatment for less the $10,000. What a grandstanding opportunity this would create. It could seriously complicate matters.
Cheers
PAA, A New Dawn , FDA ODD Approval and Entering Phase II MND Trial, page-432
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
19.8¢ |
Change
0.003(1.28%) |
Mkt cap ! $87.89M | |||
| Open | High | Low | Value | Volume |
| 20.0¢ | 20.0¢ | 19.5¢ | $28.24K | 141.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 410913 | 19.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 20.0¢ | 602340 | 2 |
View Market Depth
| Last trade - 11.04am 11/07/2024 (20 minute delay) ? |
| PAA (ASX) Chart |